MOBILE, Ala. (AP) - Doctors in Mobile hope a new cancer therapy developed in their labs will successfully suppress advanced breast cancer in patients for whom all other treatments have failed.
25 women who are battling terminal breast cancer are needed to volunteer for a first-of-its-kind FDA-monitored clinical trial beginning as soon as next month at the Southern Cancer Center in Mobile.
After more than 30 years of research and development by scientists at the University of South Alabama College of Medicine, this immunotherapeutic vaccine technology has recently been approved for testing in humans.
One of the three men who established the new therapy, USA Department of Microbiology and Immunology Emeritus Professor Joseph Coggin, says he hopes the trial will lead to broader studies.
Coggin says if it works in Mobile with these 25 women, he's optimistic the government will let the doctors try this for earlier cancers at the National Cancer Institutes.
The Southern Cancer Center, Providence Hospital, Mobile Infirmary, USA's College of Medicine and VRI, Inc., a California investment group, are partners in the initial clinical study.